In 2024, the AI in the medical imaging market is valued at USD 5.86 billion, and it is projected to rise to over USD 20.40 billion by 2029. Despite sustained investment and an increasing array of certified products, AI adoption in healthcare is still in its early stages, requiring increased awareness among service providers and patients about its substantial benefits.

The transformative potential of AI applications in radiology is evident, but aligned incentives between suppliers, providers, and buyers are needed to ensure widespread acceptance. Innovative technologies like deep learning promise more value in diagnosis and therapy compared to traditional methods.

Download the full report to learn more.